companiesCompany
Luye Pharma Group
aka Luye Pharma Group Ltd., Luye Pharma, 绿叶制药
Luye Pharma is a Chinese pharmaceutical group, listed in Hong Kong, whose oncology business rests on paclitaxel liposome (Lipusu) and other reformulated cancer medicines.
Overview
Luye Pharma Group, based in Yantai in Shandong and listed on the Hong Kong stock exchange, develops and sells medicines in oncology, the central nervous system and cardiovascular disease, with a focus on new formulations and long-acting delivery. Its best-known cancer product is Lipusu, a liposomal formulation of paclitaxel widely used in China, and it runs phase 3 trials of reformulated chemotherapy and targeted agents. OnCo records it as a registry sponsor of phase 3 cancer trials.
Headquarters
Yantai, CN
Scorecard
All companies#72of 832 companies, score 44
- approved products +6
- modalities +2
- regions +6
- registry trials +30
1 approved, 0 in phase 3, 0 earlier, 0 targets, 4,383 registry studies. Formula on the scorecards page.
Type
pharma
Stage
Public
Website